Product Program year 2025 Source: CMS Open Payments

Xience Sierra

Device Vascular

PDI 08717648227547

Open in the dashboard

General payments

$490,151

7,132 payments

Research payments

$836,369

303 payments

Through program year 2025, $490,151 in general payments and $836,369 in research payments were reported against Xience Sierra (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 Research $1,500 1
2024 General $14,021 99
2024 Research $315 5
2023 General $64,386 1,215
2023 Research $630,613 186
2022 General $411,744 5,818
2022 Research $203,941 111

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $490,151 7,132 payments
Top recipients General payments · program year 2024
  1. Michael Happes Smithtown, NY $2,500 18% · 2 payments
  2. Jeremy Robbins Cardiovascular Disease · Boston, MA $1,300 9% · 3 payments
  3. Edwin Gravereaux Vascular Surgery · Boston, MA $1,000 7% · 2 payments
  4. Joseph Campbell Interventional Cardiology · Columbus, OH $1,000 7% · 2 payments
  5. Michael Levy Interventional Cardiology · Burlington, MA $800 6% · 1 payment

The top 5 of 73 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $3,948 40% · 25 practitioners
  2. Cardiovascular Disease Internal Medicine $2,076 21% · 8 practitioners
  3. Vascular Surgery Surgery $1,400 14% · 2 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,313 13% · 4 practitioners
  5. Vascular & Interventional Radiology Radiology $400 4% · 1 practitioner

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Massachusetts $5,002 36% · 9 recipients
  2. New York $3,112 22% · 10 recipients
  3. Ohio $1,454 10% · 11 recipients
  4. Florida $1,341 10% · 6 recipients
  5. Tennessee $1,010 7% · 6 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

7,132 general · 303 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record